Consolidation for ovarian cancer in remission
- PMID: 16446325
- DOI: 10.1200/JCO.2005.04.5138
Consolidation for ovarian cancer in remission
Comment on
-
Phase III trial of intraperitoneal therapy with yttrium-90-labeled HMFG1 murine monoclonal antibody in patients with epithelial ovarian cancer after a surgically defined complete remission.J Clin Oncol. 2006 Feb 1;24(4):571-8. doi: 10.1200/JCO.2005.02.5973. J Clin Oncol. 2006. PMID: 16446329 Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous